236 related articles for article (PubMed ID: 31369887)
1. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.
van Rossum PSN; Deng W; Routman DM; Liu AY; Xu C; Shiraishi Y; Peters M; Merrell KW; Hallemeier CL; Mohan R; Lin SH
Pract Radiat Oncol; 2020; 10(1):e16-e26. PubMed ID: 31369887
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
3. Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: Incidence and external validation of a prediction model.
Kroese TE; Jairam J; Ruurda JP; Lin SH; Mohan R; Mook S; Haitjema S; Hoefer I; Haj Mohammad N; Peters M; van Hillegersberg R; van Rossum PSN
Radiother Oncol; 2021 Oct; 163():192-198. PubMed ID: 34453954
[TBL] [Abstract][Full Text] [Related]
4. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.
Goense L; Merrell KW; Arnett AL; Hallemeier CL; Meijer GJ; Ruurda JP; Hofstetter WL; van Hillegersberg R; Lin SH
Ann Thorac Surg; 2018 Nov; 106(5):1541-1547. PubMed ID: 29932887
[TBL] [Abstract][Full Text] [Related]
6. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
Shiraishi Y; Fang P; Xu C; Song J; Krishnan S; Koay EJ; Mehran RJ; Hofstetter WL; Blum-Murphy M; Ajani JA; Komaki R; Minsky B; Mohan R; Hsu CC; Hobbs BP; Lin SH
Radiother Oncol; 2018 Jul; 128(1):154-160. PubMed ID: 29248170
[TBL] [Abstract][Full Text] [Related]
7. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
[TBL] [Abstract][Full Text] [Related]
8. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
9. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer.
Xu Y; Wang L; He B; Li W; Wen Q; Wang S; Sun X; Meng X; Yu J
Radiat Oncol; 2019 Oct; 14(1):181. PubMed ID: 31640802
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
12. A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy.
Wang L; Liang S; Li C; Sun X; Pang L; Meng X; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1074-1085. PubMed ID: 31461673
[TBL] [Abstract][Full Text] [Related]
13. Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.
Chen X; Tian X; Zhang X; Deng Q; Wang M; Zhou X; Xu Y; Zhou L; Zou B; Liu Y; Ao R; Lu Y; Gong Y
Thorac Cancer; 2023 Sep; 14(27):2735-2744. PubMed ID: 37519061
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.
Wild AT; Ye X; Ellsworth SG; Smith JA; Narang AK; Garg T; Campian J; Laheru DA; Zheng L; Wolfgang CL; Tran PT; Grossman SA; Herman JM
Am J Clin Oncol; 2015 Jun; 38(3):259-65. PubMed ID: 23648440
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer.
Toxopeus EL; Nieboer D; Shapiro J; Biermann K; van der Gaast A; van Rij CM; Steyerberg EW; van Lanschot JJ; Wijnhoven BP
Radiother Oncol; 2015 Jun; 115(3):392-8. PubMed ID: 26116340
[TBL] [Abstract][Full Text] [Related]
16. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.
Fang P; Jiang W; Davuluri R; Xu C; Krishnan S; Mohan R; Koong AC; Hsu CC; Lin SH
Radiother Oncol; 2018 Sep; 128(3):584-590. PubMed ID: 29530432
[TBL] [Abstract][Full Text] [Related]
17. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
18. External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer.
Schuring N; Donlon NE; Hagens ERC; Gootjes D; Donohoe CL; van Berge Henegouwen MI; Reynolds JV; Gisbertz SS
Surgery; 2023 Dec; 174(6):1363-1370. PubMed ID: 37735034
[TBL] [Abstract][Full Text] [Related]
19. Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy.
Li Q; Zhou S; Liu S; Liu S; Yang H; Zhao L; Liu M; Hu Y; Xi M
Ann Surg Oncol; 2019 Sep; 26(9):2882-2889. PubMed ID: 31037433
[TBL] [Abstract][Full Text] [Related]
20. Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning.
Zhu C; Mohan R; Lin SH; Jun G; Yaseen A; Jiang X; Wang Q; Cao W; Hobbs BP
JCO Clin Cancer Inform; 2021 Sep; 5():1044-1053. PubMed ID: 34665662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
